79230436

Information

• Trademark
• 79230436

• Source

• Serial Number

  79230436

• Registration Number

  5759811

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  January 18, 2018
  7 years ago

• Registration Date

  May 28, 2019
  5 years ago

• Transaction Date

  June 16, 2024
  8 months ago

• Status Date

  May 28, 2019
  5 years ago

• Published for Opposition Date

  February 12, 2019
  6 years ago

• Location Date

  May 28, 2019
  5 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  COLLOPY, DIANE PATRICI

• Attorney Docket Number

  SW-MERXTM02

  Attorney Name

  Sean D. Detweiler

  Law Office Assigned Location Code

  L70

• Owners

  • Merxin Ltd

Case File Statements

• DM0000: The mark consists of a maroon zigzag line with a grey oval placed under the left side of the line.
• GS0091: Vials for scientific purposes being laboratory equipment; Vials for laboratory use; Glass tubes for scientific purposes being laboratory equipment, none of the aforesaid being additive manufacturing devices or 3D devices
• GS0051: Pharmaceuticals for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical compositions for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders adapted for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders for delivery into the body via the lungs or via the nasal passageway; Pharmaceutical preparations for inhalers, namely, medical pharmaceutical compositions for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders structured for delivery into the body by nebulizer, aerosol, or dry powder, via the lungs or via the nasal passageway; Dietary supplements; Pharmaceutical products for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
• CC0000: The color(s) maroon and grey is/are claimed as a feature of the mark.
• GS0441: Pharmaceutical compounding services; Pharmaceutical compounding consultation services; Pharmaceutical compounding advisory services; Medical services; Veterinary services; Hygienic and beauty care for animals; Hygienic and beauty care for humans
• GS0101: Surgical, medical, dental and veterinary apparatus and instruments, namely, injection devices for administering drugs sold empty; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical syringes sold empty for administering pharmaceuticals; Medical apparatus for introducing pharmaceutical preparations into the human body; Inhalers for medical use; Medical inhalers; Respiratory monitors for medical use; Apparatus for measuring lung function; Spirometers for examining the function of the lungs; Spirometers; Spirometer mouth pieces and tubing; breath gas analyzers for medical diagnostics; Replacement cartridges for medical inhalers sold empty; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of asthma and respiratory diseases
• GS0421: Scientific and technological services, namely, research and design in the field of drug delivery via the lungs or via the nasal passageway; Scientific and technological design of new products for others; Advisory services relating to design engineering; Advisory services relating to product testing; Product design and development in the field of drug delivery via the lungs or via the nasal passageway; New product design services, namely, analysis and evaluation of product design; engineering design and consultancy; Professional consultancy relating to medical technology; engineering project management services, not for business purposes; Engineering research; Pharmaceutical research and development services; research and development for the pharmaceutical industry; Research relating to medicines; none of the aforesaid in relation to additive manufacturing services or 3D printing services

Case File Event Statements

• 4/27/2018 - 6 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 4/19/2018 - 6 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 4/20/2018 - 6 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 4/24/2018 - 6 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 4/28/2018 - 6 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/29/2018 - 6 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 5/1/2018 - 6 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 5/1/2018 - 6 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 5/20/2018 - 6 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 7/25/2018 - 6 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 7/25/2018 - 6 years ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/26/2018 - 6 years ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/1/2018 - 6 years ago

  13 - FINAL REFUSAL WRITTEN Type: CNFR

• 8/1/2018 - 6 years ago

  14 - FINAL REFUSAL MAILED Type: CNFR

• 11/2/2018 - 6 years ago

  15 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG

• 12/13/2018 - 6 years ago

  16 - LIMITATION FROM THE IB - REQUEST EXAM REVIEW Type: LIME

• 12/19/2018 - 6 years ago

  17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 12/19/2018 - 6 years ago

  18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/19/2018 - 6 years ago

  19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/20/2018 - 6 years ago

  20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 12/20/2018 - 6 years ago

  21 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 12/20/2018 - 6 years ago

  22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/21/2018 - 6 years ago

  23 - EXAMINERS AMENDMENT MAILED Type: CNEA

• 1/23/2019 - 6 years ago

  24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/23/2019 - 6 years ago

  25 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 1/23/2019 - 6 years ago

  26 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 2/8/2019 - 6 years ago

  27 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 2/12/2019 - 6 years ago

  28 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/12/2019 - 6 years ago

  29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/8/2019 - 5 years ago

  30 - WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST Type: ISMR

• 4/24/2019 - 5 years ago

  31 - EXAMINERS AMENDMENT MAILED Type: CNEA

• 5/28/2019 - 5 years ago

  32 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 6/14/2019 - 5 years ago

  33 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH

• 8/28/2019 - 5 years ago

  34 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 9/27/2019 - 5 years ago

  37 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 9/9/2019 - 5 years ago

  35 - FINAL DISPOSITION PROCESSED Type: FIMP

• 9/9/2019 - 5 years ago

  36 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 5/28/2024 - 8 months ago

  38 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 6/16/2024 - 8 months ago

  39 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP